You have successfully logged out.
What are you looking for?
OnGuard® 2 Closed System Transfer Device
The vapor is invisible, but the danger is real
The OnGuard 2 Closed System Transfer Device (CSTD) Family of Products is the only system tested with real hazardous drugs resulting in data-proven protection.1
The danger of handling hazardous drugs is there—you just can't see it. OnGuard 2 CSTD provides safety and simplicity that's backed by science.
- Tested and passed a testing protocol based on the 2016 National Institute for Occupational Safety and Health (NIOSH) draft protocol for CSTDs, mechanically prohibiting the escape of hazardous drugs into the environment.
- Passed Microbial Ingress testing for up to seven days and 10 activations.
Safety that's proven
OnGuard 2 is the only CSTD tested with real hazardous drug solvents for vapor containments.1
- Compatible with known hazardous drugs to minimize exposure during preparation and injection
- Membrane-to-membrane connection is designed for a dry disconnect1
- Located in the vial adaptor, patented TOXI-GUARD® Air-Cleaning Technology designed to prevent the escape of cytotoxic and other hazardous drug vapors, aerosols and droplets into the environment during reconstitution. Additionally, TOXI-GUARD prevents airborne contaminants and particles from entering the vial
Included safety features
Designed to offer simplicity to the entire health system
The OnGuard 2 CSTD is designed to minimize the number of components.
- Fewer SKUs can reduce parts and long-term costs. In fact, only four SKUs enable 98% of preparations and administrations.*
- Fewer components means OnGuard 2 CSTD can cut storage space by 10-15% and reduce carrying cost by 5%2
For those who handle hazardous drugs, OnGuard 2 CSTD helps:
- Save compounding time
- Reduce repetitive motion
- Limit drug waste
- Improve SKU rationalization
Additional OnGuard 2 CSTD Information
Learn more about the safety and simplicity offered by OnGuard 2 CSTD with these helpful downloads.
Discover moreReferences
- Levin G, Sessink PJ. Validation of chemotherapy drug vapor containment of an air cleaning closed-system drug transfer device. J. Oncol. Pharm. Pract. 2022;28(7):1508-1515. https://foi.oth/10.1177/10781552211030682.
- Jorgenson JA. Maximizing your CSTD return on investment. Pharmacy Practice News. 2017. https://www.pharmacypracticenews.com/Policy/Article/11-17/Maximizing-Your-CSTD-Return-on-Investment/45194.
*Based on average sales and in-use market in preparation - 20mm vial adaptor, syringe adaptor, bag adaptor, Luer Lock Adaptor